Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa open-label single-arm study of ALMB-0168 in advanced solid tumors with bone metastases
CTR20241498Phase 2Active
- Sponsor
- Enlemai
- Start
- Apr 2024
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of ALMB-0168 in breast cancer, prostate cancer (PCa), sponsored by Enlemai. Started Apr 2024; status: active.
02
Drugs
ALMB-0168
03
Conditions
breast cancerprostate cancer (PCa)
Beyond the preview
Go deeper on CTR20241498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241498.